Risk factors for thrombosis and the beneficial effect of aspirin in patients with antiphospholipid antibodies (aPL)

被引：3
|
作者：
Hansen, KE
Kramm, HL
Boh, D
Bell, CB
Perry, S
Potti, A
Ortel, TL
机构：
[1] Univ Wisconsin, Dept Med, Madison, WI USA
[2] Duke Univ, Med Ctr, Div Hematol, Durham, NC USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.279.279
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
279
引用
收藏
页码：83A / 83A
页数：1
相关论文
共 50 条
  • [21] Homocysteine, antiphospholipid antibodies and risk of thrombosis in patients with systemic lupus erythematosus
    Martínez-Berriotxoa, A
    Ruiz-Irastorza, G
    Egrubide, MV
    Rueda, M
    Aguirre, C
    LUPUS, 2004, 13 (12) : 927 - 933
  • [22] Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: A prospective case-control study
    Williams, GA
    Sarrafizadeh, R
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2000, 130 (04) : 538 - 538
  • [23] Antiphospholipid antibodies and retinal thrombosis in patients without risk factors:: A prospective case-control study
    Cobo-Soriano, R
    Sánchez-Ramón, S
    Aparicio, MJ
    Teijeiro, MA
    Vidal, P
    Suárez-Leoz, M
    Rodriguez-Mahou, M
    Rodriguez-Huerta, A
    Fernández-Cruz, E
    Cortés, C
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1999, 128 (06) : 725 - 732
  • [24] COMPARATIVE STUDY OF RISK FACTORS FOR VENOUS AND ARTERIAL THROMBOSIS IN CARRIERS OF ANTIPHOSPHOLIPID ANTIBODIES
    Les, I.
    Vidal, C. J.
    Anaut, P.
    Sanchez, C.
    Andia, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1062 - 1062
  • [25] A MULTICENTER PROSPECTIVE EVALUATION OF THE RISK PROFILE IN PREGNANT PATIENTS WITH PERSISTENT POSITIVITY FOR ANTIPHOSPHOLIPID ANTIBODIES (APL)
    Fredi, M.
    Aggogeri, E.
    Bettiga, E.
    Andreoli, L.
    Lazzaroni, M. G.
    Le Guern, V.
    Lojacono, A.
    Morel, N.
    Nalli, C.
    Taraborelli, M.
    Zatti, S.
    Piette, J. C.
    Costedoat-Chalumeau, N.
    Tincani, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 575 - 575
  • [26] Complement Activation In Patients with Isolated Antiphospholipid Antibodies (aPL) or Primary Antiphospholipid Syndrome (PAPS)
    Breen, Karen A.
    Parmar, Kiran
    Hunt, Beverley J.
    BLOOD, 2010, 116 (21) : 1713 - 1714
  • [27] Complement activation in patients with isolated antiphospholipid antibodies (aPL) and primary antiphospholipid syndrome (PAPS)
    Breen, K. A.
    Seed, P.
    Parmar, K.
    Hunt, B. J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 166 - 166
  • [28] Identifying Additional Risk Factors for Thrombosis and Pregnancy Morbidities Among Antiphospholipid Antibodies Carriers
    Zuo, Yu
    Fan, Jennifer
    Sarode, Ravi
    Zhang, Song
    Makris, Una E.
    Karp, David R.
    Shen, Yu-Min
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 (06) : 980 - 985
  • [29] THE ANALYSIS OF RISK AND PROTECTIVE FACTORS FOR THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH OR WITHOUT ANTIPHOSPHOLIPID ANTIBODIES
    Watanabe, T.
    Oku, K.
    Amengual, O.
    Shimamura, S.
    Nakagawa, I.
    Noguchi, A.
    Kanetsuka, Y.
    Kono, M.
    Kurita, T.
    Fujieda, Y.
    Bohgaki, T.
    Yasuda, S.
    Horita, T.
    Atsumi, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 482 - 482
  • [30] Factor V Leiden increases the risk of thrombosis in patients with antiphospholipid antibodies.
    Simantov, R
    Lo, SK
    Salmon, JE
    Sammaritano, LR
    Silverstein, RL
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (03) : A329 - A329
12345